Dr. Aaron Schimmer MD, PhD, FRCPC has been appointed as the new Research Director of the Princess Margaret Cancer Centre, effective February 15, 2019.
Dr. Schimmer has been an active clinician and a researcher at PM since 2003, where he has established a vibrant translational research program in developing innovative therapeutic strategies to target leukemia and leukemia stem cells.
He is a highly productive and recognized authority in the cancer research field, with over 217 peer-reviewed papers published over the course of his career, with many in high impact journals like Cancer Cell and Blood. His work in novel therapeutics has resulted in over 15 patents and patent applications and, to date, he has advanced three candidate therapeutic drugs from his lab into Phase I clinical trials.
He is also the recipient of numerous prestigious research awards, including the Till and McCulloch Award and the Bernard and Francine Dorval Prize.
Dr. Schimmer has a long list of contributions to research, clinical practice and education at UHN and the University of Toronto that is a testament to his commitment to science and research here in Toronto—an essential element for success in this new role. He has demonstrated a commitment to supporting his colleagues and to advancing the impact of Princess Margaret on the global stage.
Congratulations Dr. Schimmer!